With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development. Kalorama analyst Alison Sahoo has built models to determine the best, moderate and worst case scenarios for the three key markets for stem cells:

• Stem Cell Therapeutics (Transplantation)
• Cord Blood Banking and
• Drug development

This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:

• Cardiovascular disease
• Lung disease
• Arthritis
• Incontinence
• Osteoporosis
• Diabetes
• Cancer
• Orthopedics
• Infertility
• Alzheimer’s disease
• Burns (severe)
• Lupus
• Parkinson’s disease
• Liver failure
• Multiple sclerosis
• Critical limb ischemia
• Crohn's disease
• Sickle cell disease
• Multiple myeloma
• NH lymphoma
• Leukemia

Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:

• Aastrom Biosciences
• Advanced Cell Technologies
• Brainstorm Cell Therapeutics
• Celegene
• Cord Blood America
• Cord Blood Registry
• Cryo-Cell International
• ES Cell International
• Geron
• Harvest Technologies
• Invitrogen
• Medistem
• Neostem
• Opexa Therapeutics
• Osiris Therapeutics
• Plureon
• Regenetech
• Revivicor
• Stem Cell Sciences
• StemLifeLine
• ThermoGenesis
• VetCell Bioscience
• ViaCell

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.

Related Reports:

Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition
Dec 1, 2008 - KLI1928788 - $3,995.00

Glucose Testing Markets
Nov 1, 2008 - KLI1911068 - $1,995.00

Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
Nov 1, 2008 - KLI1816262 - $3,995.00

Key Genetic Technologies Market Research Bundle (SNPs, Gene Expression Profiling, DNA Sequencing and Biochips)
Nov 1, 2008 - KLI1689637 - $7,995.00

Smoking Cessation: World Markets
Nov 1, 2008 - KLI1646594 - $3,500.00

Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
Oct 1, 2008 - KLI1646604 - $3,500.00

Worldwide In Vitro Diagnostics Market Research Bundle (Worldwide Market for In Vitro Diagnostic Tests, SNP Genotyping Markets, Companion Diagnostics, Testing Services Markets)
Oct 1, 2008 - KLI1927625 - $7,995.00

Kalorama Medical Device Market Research Bundle: Infusion Pumps, Minimally Invasive Devices, Syringes, Hip and Knee Implants, Respiratory Equipment, Asian Device Markets, OEM Contract Manufacturing, Reusable Equipment, Catheters)
Oct 1, 2008 - KLI1927457 - $9,995.00

HIV: Markets for Diagnostics and Therapeutics
Oct 1, 2008 - KLI1646600 - $3,500.00

Minimally Invasive Surgical Devices, World Market
Sep 1, 2008 - KLI1614100 - $3,500.00